36 results
8-K
EX-1.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
if the disclosure of such additional information would result in a violation of Regulation FD.
(m) Record Retention. The Company will, pursuant to reasonable
8-K
EX-1.1
ch2k3sllio6ifvmtdmuf
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
S-3
EX-1.2
qqj nauovum1
1 Jul 22
Shelf registration
4:36pm
DEF 14A
j78pk1zzt8m
29 Apr 22
Definitive proxy
7:01am
10-K
y14wjgtof
14 Mar 22
Annual report
7:04am